Revenue held near $1.4B to $1.7B per quarter, but the combined ratio swung from 77.9% in Q3 2025 to 110.2% in Q1 2025 and 100.9% in Q3 2026, indicating underwriting results remain highly volatile.
Mercury General Corporation (MCY) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 6.14B | 5.99B | 5.48B | 4.63B | 3.64B | 3.99B | 3.78B | 3.97B | 3.38B | 3.42B | 3.23B | 3.01B | 3.01B | 2.82B | 2.78B | 2.78B | 2.78B | 3.12B | 2.41B | 3.18B | 3.17B | 2.99B | 2.67B | 2.27B | 1.79B | 1.51B | 1.37B | 1.28B | 1.22B | 1.13B | 824.96M |
| Revenue Growth % | 5.42% | 9.44% | 18.27% | 27.08% | -8.77% | 5.52% | -4.73% | 17.53% | -1.05% | 5.83% | 7.26% | -0.08% | 6.76% | 1.35% | 0.22% | 0.05% | -11.07% | 29.3% | -24.05% | 0.32% | 5.91% | 12.13% | 17.77% | 26.83% | 18.53% | 10.32% | 6.66% | 4.79% | 8.35% | 36.73% | 20.67% |
| Medical Costs & Claims | 3.4B | 3.96B | 4.54B | 4.23B | 4.02B | 3.39B | 3.02B | 3.31B | 3.15B | 3B | 2.92B | 2.68B | 2.51B | 2.47B | 2.44B | 2.31B | 2.33B | 2.54B | 2.69B | 2.7B | 2.67B | 2.48B | 2.14B | 1.93B | 1.65B | 1.31B | 1.17B | 1.06B | 937.06M | 879.61M | 661.88M |
| Medical Cost Ratio % | 55.38% | 66.13% | 82.96% | 91.29% | 110.26% | 84.98% | 79.88% | 83.27% | 93.16% | 87.83% | 90.4% | 89.21% | 83.42% | 87.49% | 87.64% | 83.21% | 83.99% | 81.47% | 111.23% | 84.82% | 84.28% | 82.95% | 80.39% | 84.99% | 92.18% | 87.07% | 85.68% | 82.5% | 76.67% | 77.98% | 80.23% |
| Gross Profit | 2.74B | 2.03B | 932.86M | 403.25M | -373.76M | 599.82M | 761.38M | 664.41M | 231.05M | 415.73M | 310M | 324.57M | 499.44M | 352.83M | 344.13M | 466.36M | 444.55M | 578.27M | -271.07M | 482.44M | 498.15M | 510.06M | 523.35M | 340.15M | 139.64M | 194.87M | 195.58M | 224.17M | 285.06M | 248.33M | 163.09M |
| Gross Margin % | 44.62% | 33.87% | 17.04% | 8.71% | -10.26% | 15.02% | 20.12% | 16.73% | 6.84% | 12.17% | 9.6% | 10.79% | 16.58% | 12.51% | 12.36% | 16.79% | 16.01% | 18.53% | -11.23% | 15.18% | 15.72% | 17.05% | 19.61% | 15.01% | 7.82% | 12.93% | 14.32% | 17.5% | 23.33% | 22.02% | 19.77% |
| Gross Profit Growth % | - | 117.55% | 131.33% | 207.89% | -162.31% | -21.22% | 14.6% | 187.56% | -44.42% | 34.11% | -4.49% | -35.01% | 41.55% | 2.53% | -26.21% | 4.9% | -23.12% | 313.33% | -156.19% | -3.16% | -2.33% | -2.54% | 53.86% | 143.59% | -28.34% | -0.36% | -12.76% | -21.36% | 14.79% | 52.27% | 17.85% |
| Operating Expenses | 1.94B | 1.37B | 357.98M | 303.82M | 296.95M | 300.51M | 302.88M | 286.34M | 261.67M | 248.64M | 239.28M | 254.01M | 252.02M | 220.74M | 208.82M | 221.26M | 262.16M | 6.73M | 179.79M | 167.4M | 185.74M | 157.42M | 115.51M | 94.35M | 78.97M | 70.06M | 67.03M | 55.63M | 49.78M | 38.55M | 26.5M |
| OpEx / Revenue % | 31.6% | 22.79% | 6.54% | 6.56% | 8.15% | 7.53% | 8% | 7.21% | 7.74% | 7.28% | 7.41% | 8.44% | 8.37% | 7.82% | 7.5% | 7.97% | 9.44% | 0.22% | 7.45% | 5.27% | 5.86% | 5.26% | 4.33% | 4.16% | 4.42% | 4.65% | 4.91% | 4.34% | 4.07% | 3.42% | 3.21% |
| Depreciation & Amortization | 82.62M | 74.99M | 73.43M | 72.24M | 82.39M | 79.06M | 68.46M | 64.73M | 58.79M | 55.34M | 53.26M | 47.84M | 28.05M | 30.59M | 36.97M | 40.66M | 40.73M | 35.69M | 27.04M | 26.32M | 24.26M | 18.78M | 16.19M | 16.13M | 10.23M | 8.48M | 6.93M | 6.9M | 5.44M | 5.16M | 4.07M |
| Combined Ratio % | 86.98% | 88.93% | 89.5% | 97.85% | 118.41% | 92.5% | 87.88% | 90.48% | 100.91% | 95.11% | 97.81% | 97.66% | 91.78% | 95.32% | 95.14% | 91.17% | 93.43% | 81.69% | 118.68% | 90.09% | 90.14% | 88.21% | 84.71% | 89.15% | 96.6% | 91.72% | 90.59% | 86.84% | 80.75% | 81.4% | 83.44% |
| Operating Income | 799.15M | 663.65M | 574.88M | 99.43M | -670.72M | 299.31M | 458.5M | 378.07M | -30.61M | 167.09M | 70.72M | 70.57M | 247.43M | 132.1M | 135.31M | 245.1M | 182.39M | 571.54M | -450.86M | 315.04M | 312.41M | 352.64M | 407.84M | 245.8M | 60.67M | 124.81M | 128.56M | 168.54M | 235.28M | 209.78M | 136.59M |
| Operating Margin % | 13.02% | 11.07% | 10.5% | 2.15% | -18.41% | 7.5% | 12.12% | 9.52% | -0.91% | 4.89% | 2.19% | 2.34% | 8.22% | 4.68% | 4.86% | 8.83% | 6.57% | 18.31% | -18.68% | 9.91% | 9.86% | 11.79% | 15.29% | 10.85% | 3.4% | 8.28% | 9.41% | 13.16% | 19.25% | 18.6% | 16.56% |
| Operating Income Growth % | - | 15.44% | 478.19% | 114.82% | -324.09% | -34.72% | 21.27% | 1334.91% | -118.32% | 136.25% | 0.22% | -71.48% | 87.31% | -2.38% | -44.79% | 34.38% | -68.09% | 226.77% | -243.11% | 0.84% | -11.41% | -13.54% | 65.92% | 305.16% | -51.39% | -2.91% | -23.72% | -28.37% | 12.16% | 53.58% | 19.48% |
| EBITDA | 881.78M | 738.64M | 648.31M | 171.67M | -588.33M | 378.36M | 526.96M | 442.8M | 28.18M | 222.43M | 123.98M | 118.41M | 275.48M | 162.68M | 172.28M | 285.76M | 223.13M | 607.23M | -423.82M | 341.36M | 336.67M | 371.42M | 424.04M | 261.93M | 70.9M | 133.29M | 135.48M | 175.44M | 240.72M | 214.94M | 140.66M |
| EBITDA Margin % | 14.36% | 12.33% | 11.84% | 3.71% | -16.15% | 9.47% | 13.92% | 11.15% | 0.83% | 6.51% | 3.84% | 3.93% | 9.15% | 5.77% | 6.19% | 10.29% | 8.04% | 19.45% | -17.56% | 10.74% | 10.62% | 12.41% | 15.89% | 11.56% | 3.97% | 8.84% | 9.92% | 13.7% | 19.7% | 19.06% | 17.05% |
| Interest Expense | 31.95M | 28.62M | 30.82M | 24.17M | 17.23M | 17.11M | 17.05M | 17.04M | 17.04M | 15.17M | 3.96M | 3.17M | 2.64M | 1.26M | 1.54M | 5.55M | 6.81M | 6.73M | 4.97M | 8.59M | 9.18M | 7.22M | 4.22M | 3.06M | 4.1M | 7.73M | 7.29M | 5M | 4.8M | 5M | 2M |
| Non-Operating Income | -21.78M | -28.62M | -30.82M | -24.17M | -17.23M | -17.11M | -17.05M | -17.04M | -17.04M | -15.17M | -3.96M | -3.17M | -2.64M | -1.26M | -1.54M | -5.55M | -6.81M | -6.73M | -4.97M | -8.59M | -9.18M | -7.22M | -4.22M | -3.06M | -4.1M | -7.73M | -7.29M | -5M | -4.8M | -5M | -2M |
| Pretax Income | 788.99M | 663.65M | 574.88M | 99.43M | -670.72M | 299.31M | 458.5M | 378.07M | -30.61M | 167.09M | 70.72M | 70.57M | 247.43M | 132.1M | 135.31M | 245.1M | 182.39M | 571.54M | -450.86M | 315.04M | 312.41M | 352.64M | 407.84M | 245.8M | 60.67M | 124.81M | 128.56M | 168.54M | 235.28M | 209.78M | 136.59M |
| Pretax Margin % | 12.85% | 11.07% | 10.5% | 2.15% | -18.41% | 7.5% | 12.12% | 9.52% | -0.91% | 4.89% | 2.19% | 2.34% | 8.22% | 4.68% | 4.86% | 8.83% | 6.57% | 18.31% | -18.68% | 9.91% | 9.86% | 11.79% | 15.29% | 10.85% | 3.4% | 8.28% | 9.41% | 13.16% | 19.25% | 18.6% | 16.56% |
| Income Tax | 146.2M | 122.56M | 106.93M | 3.09M | -158.04M | 51.37M | 83.89M | 57.98M | -24.89M | 22.21M | -2.32M | -3.91M | 69.48M | 19.95M | 18.4M | 53.94M | 30.19M | 168.47M | -208.74M | 77.2M | 97.59M | 99.38M | 121.64M | 61.48M | -5.44M | 19.47M | 19.19M | 34.83M | 57.75M | 53.47M | 30.83M |
| Effective Tax Rate % | 18.53% | 18.47% | 18.6% | 3.11% | 23.56% | 17.16% | 18.3% | 15.34% | 81.29% | 13.29% | -3.28% | -5.54% | 28.08% | 15.1% | 13.6% | 22.01% | 16.55% | 29.48% | 46.3% | 24.51% | 31.24% | 28.18% | 29.82% | 25.01% | -8.96% | 15.6% | 14.93% | 20.67% | 24.55% | 25.49% | 22.57% |
| Net Income | 642.78M | 541.09M | 467.95M | 96.34M | -512.67M | 247.94M | 374.61M | 320.09M | -5.73M | 144.88M | 73.04M | 74.48M | 177.95M | 112.14M | 116.91M | 191.16M | 152.2M | 403.07M | -242.12M | 237.83M | 214.82M | 253.26M | 286.21M | 184.32M | 66.11M | 105.34M | 109.37M | 133.71M | 177.53M | 156.31M | 105.76M |
| Net Margin % | 10.47% | 9.03% | 8.55% | 2.08% | -14.07% | 6.21% | 9.9% | 8.06% | -0.17% | 4.24% | 2.26% | 2.47% | 5.91% | 3.98% | 4.2% | 6.88% | 5.48% | 12.91% | -10.03% | 7.48% | 6.78% | 8.46% | 10.73% | 8.14% | 3.7% | 6.99% | 8.01% | 10.44% | 14.53% | 13.86% | 12.82% |
| Net Income Growth % | 46.22% | 15.63% | 385.75% | 118.79% | -306.78% | -33.81% | 17.03% | 5688.11% | -103.95% | 98.34% | -1.93% | -58.15% | 58.68% | -4.08% | -38.84% | 25.6% | -62.24% | 266.48% | -201.8% | 10.71% | -15.18% | -11.51% | 55.28% | 178.83% | -37.25% | -3.68% | -18.21% | -24.68% | 13.58% | 47.79% | 17.12% |
| EPS (Diluted) | 11.60 | 9.77 | 8.45 | 1.74 | -9.26 | 4.48 | 6.77 | 5.78 | -0.10 | 2.62 | 1.32 | 1.35 | 3.23 | 2.04 | 2.13 | 3.49 | 2.78 | 7.32 | -4.41 | 4.34 | 3.92 | 4.63 | 5.24 | 3.38 | 1.21 | 1.94 | 2.02 | 2.44 | 3.21 | 2.82 | 1.93 |
| EPS Growth % | 46.41% | 15.62% | 385.63% | 118.79% | -306.7% | -33.83% | 17.13% | 5880% | -103.82% | 98.48% | -2.22% | -58.2% | 58.33% | -4.23% | -38.97% | 25.54% | -62.02% | 265.99% | -201.61% | 10.71% | -15.33% | -11.64% | 55.03% | 179.34% | -37.63% | -3.96% | -17.21% | -23.99% | 13.83% | 46.11% | 16.27% |
| EPS (Basic) | - | 9.77 | 8.45 | 1.74 | -9.26 | 4.48 | 6.77 | 5.78 | -0.10 | 2.62 | 1.32 | 1.35 | 3.23 | 2.04 | 2.13 | 3.49 | 2.78 | 7.36 | -4.42 | 4.35 | 3.93 | 4.64 | 5.25 | 3.39 | 1.22 | 1.94 | 2.02 | 2.45 | 3.23 | 2.84 | 1.93 |
| Diluted Shares Outstanding | 55.39M | 55.39M | 55.38M | 55.37M | 55.37M | 55.37M | 55.36M | 55.36M | 55.34M | 55.33M | 55.3M | 55.21M | 55.02M | 54.96M | 54.92M | 54.84M | 54.83M | 55.09M | 54.92M | 54.83M | 54.8M | 54.7M | 54.62M | 54.53M | 54.63M | 54.3M | 54.14M | 54.8M | 55.3M | 55.43M | 54.96M |
Quick answers to the most common questions about buying MCY stock.
For fiscal year 2025, Mercury General Corporation (MCY) reported total revenue of $5.99B. This represents a 626.4% increase compared to $825.0M in 1996.
Mercury General Corporation (MCY) is profitable, generating $541.1M in net income for the fiscal year ending 2025 with a net profit margin of 9.0%.
Mercury General Corporation (MCY) reported an operating income of $663.6M, resulting in an operating profit margin of 11.1%. This margin reflects the operational efficiency of the business before interest and taxes.
Mercury General Corporation (MCY) generated $2.03B in gross profit for the year, representing a gross profit margin of 33.9%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
California regulatory and catastrophe exposure
Metrics are mathematically derived from official filings.
Rate Actions Driving Top-Line Growth
Based on reported quarterly figures, Mercury's revenue grew 13.8% in Q2 2026 and 10.5% in Q1 2026, though Q3 2026 revenue fell 12.8%, suggesting top-line momentum is uneven and rate-driven rather than volume-driven.
The pattern across the ten reported quarters points to premium growth being supported by California rate approvals rather than sustained policy count expansion. The sharp Q3 2026 decline, if confirmed in subsequent filings, would warrant investigation into whether rate adequacy has been offset by policy attrition or seasonal homeowners losses. Investors should monitor whether revenue growth can persist once the initial wave of approved increases annualizes.
Combined Ratio Swings Expose Underwriting Volatility
As reported in quarterly statements, Mercury's combined ratio ranged from 77.9% to 110.2% over the period, with Q1 2025 and Q3 2026 breaching 100%, indicating underwriting losses in those quarters that required investment income to offset.
The wide dispersion in combined ratios suggests that underlying loss severity inflation, particularly in auto repair and litigation costs, has not been consistently neutralized by pricing. Reported loss ratios of 60.6% in Q1 2026 versus 104.0% in Q1 2025 indicate that results remain highly sensitive to catastrophe timing and claims cost lag. The Q3 2026 combined ratio of 100.9% alongside a net loss suggests underwriting margins may still be fragile despite recent rate increases.
Earnings Quality Hinges on Reserve Releases
Based on Mercury's reported figures, the Q2 2026 EPS of $4.76 against a consensus near $2.15 represents a substantial beat, and the magnitude relative to 13.8% revenue growth warrants scrutiny of whether prior-year reserve development contributed materially.
A beat of this size relative to top-line growth may indicate that favorable prior-year reserve development or one-time items influenced reported earnings, rather than core underwriting improvement alone. The reported Q4 2025 loss ratio of 14.8% is markedly below adjacent quarters, which appears inconsistent with steady-state auto claims costs and could reflect reserve releases. Investors should examine the reserve roll-forward to distinguish sustainable margin recovery from timing effects.
Investment Income Data Remains Unavailable
Investment income and investment yield figures are not reported in the supplied quarterly data, so the contribution of portfolio returns to total earnings cannot be quantified from the figures provided.
Without reported investment income, it is not possible to assess how much of net income in profitable quarters depended on fixed-income yields versus underwriting results. This gap limits conclusions about the offset capacity of the portfolio during quarters with combined ratios above 100%, such as Q1 2025 and Q3 2026. Analysts should consult the full statutory filings to evaluate investment income sensitivity to rate movements.
Q1 2025 Marks the Underwriting Trough
According to reported quarterly data, Q1 2025 delivered a net loss of $108.3 million with a 104.0% loss ratio and 110.2% combined ratio, representing the weakest underwriting quarter in the ten-quarter window and a clear inflection point.
The Q1 2025 result coincides with a 9.4% revenue increase, indicating that premiums were growing while claims costs outpaced them, consistent with severity inflation before rate relief fully flowed through. The subsequent recovery to a 77.9% combined ratio in Q3 2025 suggests that the rate environment and claims management improved within two quarters. Whether this represents a durable turn or a cyclical trough remains an open question given the Q3 2026 relapse.
Earnings Recovery May Prove Fragile
Based on reported figures, the bull case rests on rate adequacy catching up with claims inflation, but the Q3 2026 net loss and 100.9% combined ratio following a 77.9% quarter suggest recovery could reverse quickly if severity trends persist.
The strongest challenge to the reported recovery is that the Q2 2026 beat may reflect timing benefits from reserve development and low-loss quarters, such as the 14.8% loss ratio in Q4 2025, rather than a durable shift in underwriting economics. If auto repair and litigation severity continue to outpace approved California rate increases, the combined ratio may remain near or above 100% despite headline revenue growth. Investors should weigh whether the Q3 2026 reversal is an outlier or an early signal that margin improvement is less sustainable than the recent EPS figures imply.